Radiotherapy in the management of synchronous metastatic lung cancer

Cancer Radiother. 2023 Aug 11:S1278-3218(23)00135-X. doi: 10.1016/j.canrad.2023.03.002. Online ahead of print.ABSTRACTMetastatic lung cancer classically portends a poor prognosis. The management of metastatic lung cancer has dramatically changed with the emergence of immune checkpoint inhibitors, targeted therapy and due to a better understanding of the oligometastatic process. In metastatic lung cancers, radiation therapy which was only used with palliative intent for decades, represents today a promising way to treat primary and oligometastatic sites with a curative intent. Herein we present through a literature review the role of radiotherapy in the management of synchronous metastatic lung cancers.PMID:37574329 | DOI:10.1016/j.canrad.2023.03.002

Source: Cancer Radiotherapie - August 13, 2023 Category: Cancer & Oncology Authors: J Khalifa A L évy L-M Sauvage S Thureau J Darr éon C Le P échoux D Lerouge N Pourel D Antoni E Blais É Martin A Marguerit P Giraud F-G Riet Source Type: research